ClinicalTrials.gg
Sign In

Uterine Prolapse clinical trials

The registry lists 111 studies for Uterine Prolapse across more than 10 countries. 18 are recruiting or about to start. 70 of them are mainly about Uterine Prolapse (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-30.

Get an email when these change. Save the Uterine Prolapse studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
54
Status unknown
28
Recruiting
16
Active, not recruiting
7
Terminated
4
Enrolling by invitation
1

Phase

Phase 4
11
Phase 2
3
Phase 1
2
Phase 3
1

Where

United States
39
France
7
Turkey
7
Denmark
6
Egypt
5
Germany
5

Who runs them

Atlantic Health System (6) · Fatih Sultan Mehmet Training and Research Hospital (3) · Zealand University Hospital (3) · Coloplast A/S (3) · The Cleveland Clinic (3) · Centre Hospitalier Universitaire de Nīmes (3) · Karolinska Institutet (2) · University of Texas Southwestern Medical Center (2)

What is being tested here

Drugs under test in Uterine Prolapse studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Conjugated estrogens001
Lidocaine Topical001
Dexamethasone001
Ropivacaine001
Liposomal Bupivacaine001
Bupivacaine001
Cefuroxime001

Coming up

0phase 3 studies under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 16 Uterine Prolapse studies recruiting now, 10 (63%) set no upper age limit and 5 (31%) stop at 75 or younger. 1 (6%) take children under 18. 15 (94%) are for women only and 0 (0%) for men only; 2 (13%) take healthy volunteers.

Recruiting studies that take each age, of 16
AgeWomenMen
101 (6%)0 (0%)
1810 (63%)1 (6%)
3012 (75%)1 (6%)
4014 (88%)1 (6%)
5015 (94%)1 (6%)
6515 (94%)1 (6%)
7513 (81%)1 (6%)
8511 (69%)1 (6%)

Across all 111 studies, recruiting or not: 19% stop at 75 or younger and 10% at 65; 5% take children; 97% are for women only and 1% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Uterine Prolapse studies take

Of 37 interventional studies with no phase under Uterine Prolapse, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo13–68 · 37 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 111. Browse all 111 → or search them.